Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.39 |
| ▸ | P2RX7 | Q99572 | 5/20 | 0.38 |
| ▸ | PDE4A | P27815 | 1/20 | 0.38 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.38 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.38 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.38 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3535897 | 0.86 | HSD11B1 (0.39) | KDM4EL3MBTL1P2RX7HSD11B1TDP1 | |
| SCHEMBL3526806 | 0.85 | GRM2 (0.37) | KDM4EL3MBTL1P2RX7CNR2HSD11B1 | |
| SCHEMBL3533292 | 0.80 | HSD11B1 (0.46) | KDM4EALDH1A1L3MBTL1HSD11B1TDP1 | |
| SCHEMBL3533055 | 0.79 | PDE4A (0.39) | KDM4EALDH1A1ATML3MBTL1P2RX7 | |
| SCHEMBL3526762 | 0.79 | HSD11B1 (0.43) | KDM4EALDH1A1ATML3MBTL1P2RX7 | |
| SCHEMBL3531778 | 0.78 | HSD11B1 (0.44) | P2RX7SIGMAR1HSD11B1CYP3A4 | |
| SCHEMBL3531263 | 0.78 | HSD11B1 (0.53) | ALDH1A1SIGMAR1HSD11B1CYP3A4ADRA1D | |
| SCHEMBL3529340 | 0.75 | HSD11B1 (0.45) | KDM4EALDH1A1L3MBTL1HSD11B1TDP1 | |
| SCHEMBL3530097 | 0.71 | CYP3A4 (0.43) | KDM4EALDH1A1HSD11B1TDP1CYP3A4 | |
| SCHEMBL3529672 | 0.70 | HSD11B1 (0.45) | ALDH1A1HSD11B1CYP3A4ADRA1DADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7652057-B2 | Pyrazolones as 11b-HSD1 inhibitors for diabetes | HOFFMAN-LA ROCHE INC. (US) | 2010-01-26 | — | — | US | disclosed |
| US-20070049574-A1 | New pyrazolones as 11b-HSD1 inhibitors for diabetes | F. HOFFMANN-LA ROCHE AG (CH) | 2007-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070049574-A1 | New pyrazolones as 11b-HSD1 inhibitors for diabetes | HSD11B1, HSD17B1, HSD17B7 | KDM4E 2143/4885ALDH1A1 105/4885ATM 3006/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.